Imperial College London

ProfessorDominicWithers

Faculty of MedicineInstitute of Clinical Sciences

Clinical Chair in Diabetes & Endocrinology
 
 
 
//

Contact

 

d.withers

 
 
//

Location

 

Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Malehmir:2022:10.1038/s41591-022-01693-7,
author = {Malehmir, M and Pfister, D and Gallage, S and Szydlowska, M and Inverso, D and Kotsiliti, E and Leone, V and Peiseler, M and Surewaard, BGJ and Rath, D and Ali, A and Wolf, MJ and Drescher, H and Healy, ME and Dauch, D and Kroy, D and Krenkel, O and Kohlhepp, M and Engleitner, T and Olkus, A and Sijmonsma, T and Volz, J and Deppermann, C and Stegner, D and Helbling, P and Nombela-Arrieta, C and Rafiei, A and Hinterleitner, M and Rall, M and Baku, F and Borst, O and Wilson, CL and Leslie, J and O'Connor, T and Weston, CJ and Chauhan, A and Adams, DH and Sheriff, L and Teijeiro, A and Prinz, M and Bogeska, R and Anstee, N and Bongers, MN and Notohamiprodjo, M and Geisler, T and Withers, DJ and Ware, J and Mann, DA and Augustin, HG and Vegiopoulos, A and Milsom, MD and Rose, AJ and Lalor, PF and Llovet, JM and Pinyol, R and Tacke, F and Rad, R and Matter, M and Djouder, N and Kubes, P and Knolle, PA and Unger, K and Zender, L and Nieswandt, B and Gawaz, M and Weber, A and Heikenwalder, M},
doi = {10.1038/s41591-022-01693-7},
journal = {NATURE MEDICINE},
pages = {600--600},
title = {Platelet GPIb alpha is a mediator and potential interventional target for NASH and subsequent liver cancer (vol 25, pg 641, 2019)},
url = {http://dx.doi.org/10.1038/s41591-022-01693-7},
volume = {28},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Malehmir,M
AU - Pfister,D
AU - Gallage,S
AU - Szydlowska,M
AU - Inverso,D
AU - Kotsiliti,E
AU - Leone,V
AU - Peiseler,M
AU - Surewaard,BGJ
AU - Rath,D
AU - Ali,A
AU - Wolf,MJ
AU - Drescher,H
AU - Healy,ME
AU - Dauch,D
AU - Kroy,D
AU - Krenkel,O
AU - Kohlhepp,M
AU - Engleitner,T
AU - Olkus,A
AU - Sijmonsma,T
AU - Volz,J
AU - Deppermann,C
AU - Stegner,D
AU - Helbling,P
AU - Nombela-Arrieta,C
AU - Rafiei,A
AU - Hinterleitner,M
AU - Rall,M
AU - Baku,F
AU - Borst,O
AU - Wilson,CL
AU - Leslie,J
AU - O'Connor,T
AU - Weston,CJ
AU - Chauhan,A
AU - Adams,DH
AU - Sheriff,L
AU - Teijeiro,A
AU - Prinz,M
AU - Bogeska,R
AU - Anstee,N
AU - Bongers,MN
AU - Notohamiprodjo,M
AU - Geisler,T
AU - Withers,DJ
AU - Ware,J
AU - Mann,DA
AU - Augustin,HG
AU - Vegiopoulos,A
AU - Milsom,MD
AU - Rose,AJ
AU - Lalor,PF
AU - Llovet,JM
AU - Pinyol,R
AU - Tacke,F
AU - Rad,R
AU - Matter,M
AU - Djouder,N
AU - Kubes,P
AU - Knolle,PA
AU - Unger,K
AU - Zender,L
AU - Nieswandt,B
AU - Gawaz,M
AU - Weber,A
AU - Heikenwalder,M
DO - 10.1038/s41591-022-01693-7
EP - 600
PY - 2022///
SN - 1078-8956
SP - 600
TI - Platelet GPIb alpha is a mediator and potential interventional target for NASH and subsequent liver cancer (vol 25, pg 641, 2019)
T2 - NATURE MEDICINE
UR - http://dx.doi.org/10.1038/s41591-022-01693-7
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000757709400001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 28
ER -